Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2021-04-20 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
独立董事关于公司第五届董事会第八次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on various matters discussed at the eighth meeting of the fifth board of directors of Guangzhou Yangpu Medical Technology Co., Ltd. It covers topics such as the 2020 profit distribution plan, internal control self-evaluation report, subsidiary restructuring and related party transactions, credit line applications, shareholder return planning, audit firm reappointment, related party transactions forecast, amendments to the company charter, and special statements on related party fund occupation and external guarantees. The document is a formal opinion letter from independent directors rather than a full financial report or announcement. It does not contain financial statements or detailed financial data but provides governance-related opinions and approvals on corporate matters. This fits best under Board/Management Information (MANG), which includes announcements of board-related decisions and opinions.
2021-04-20 Chinese
关于子公司重组暨关联交易的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Guangzhou Yangpu Medical Technology Co., Ltd. regarding a subsidiary restructuring and related party transaction. It details the transaction structure, valuation, financial data of involved entities, approvals by the board and independent directors, and compliance with relevant laws and regulations. The document does not contain comprehensive financial statements or detailed financial performance analysis typical of an annual or interim report. It is a formal disclosure of a corporate transaction affecting shareholding and corporate structure, which fits the category of Capital/Financing Update (CAP). The document length is 4414 characters, which is sufficient for a detailed announcement but not a full financial report. There is no indication that this is a report publication announcement or a regulatory filing of a different nature. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2021-04-20 Chinese
关于召开2020年度业绩说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement about the scheduling of a 2020 annual performance explanation meeting (业绩说明会) by Guangzhou Yangpu Medical Technology Co., Ltd. It references the 2020 annual report having been disclosed on April 21, 2021, and invites investors to participate in an online meeting on April 23, 2021. The document does not contain the actual annual report or detailed financial data but rather serves as a notice for an investor presentation event related to the annual results. Given the content and length (830 characters), this is not the annual report itself but an announcement of an event to explain the annual performance, fitting the category of Investor Presentation (IP).
2021-04-20 Chinese
关于召开2020年年度股东大会的通知
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2020 Annual General Meeting (AGM) of Guangzhou Yangpu Medical Technology Co., Ltd. It includes information about the meeting date, agenda items to be discussed and voted on, voting procedures (both in-person and online), registration details, and proxy forms. The document does not contain the actual annual report or financial statements but rather the notification and procedural details for the AGM. This matches the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or notices about the AGM itself. The document length is about 5,489 characters, which is consistent with a detailed AGM notice rather than a full annual report or other filings. Therefore, the correct classification is AGM Information (AGM-R).
2021-04-20 Chinese
未来三年股东回报规划（2021年-2023年）
Notice of Dividend Amount Classification · 85% confidence The document is titled '未来三年股东回报规划（2021年-2023年）' which translates to 'Future Three-Year Shareholder Return Plan (2021-2023)'. It outlines the company's dividend policy and shareholder return strategy over a multi-year period. The content focuses on dividend distribution principles, cash dividend policies, and shareholder return mechanisms. It is a planning document related to dividends rather than an announcement of dividend amounts or payment dates. It does not contain actual financial statements or earnings data, nor is it a report publication announcement. It is a formal policy document regarding dividends and shareholder returns. Therefore, the most appropriate classification is Notice of Dividend Amount (DIV), as it relates to dividend policy and shareholder returns planning.
2021-04-20 Chinese
独立董事2020年度述职报告（康熙雄）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director 2020 Annual Work Report" for Guangzhou Yangpu Medical Technology Co., Ltd. It details the independent director's attendance at board and shareholder meetings, opinions on various board resolutions, committee work, on-site investigations, investor protection efforts, training, and other duties during the 2020 fiscal year. The content is a detailed narrative report of the independent director's activities and responsibilities over the year, rather than a financial report or announcement. It does not contain financial statements or audit results, nor is it a brief announcement or certification. This type of document fits best under Board/Management Information (MANG), as it relates to management and board activities and disclosures about director duties and governance involvement.
2021-04-20 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.